Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE: Self-Administration of Bortezomib at Home
NCT04268199Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- May 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by American Health Staffing Group. Started May 2020; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04268199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04268199.